Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia

Heavy Chain ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Chain Gene ◽

Minor Groove Binder ◽

Heavy Chain Gene ◽

Variable Heavy ◽

Faculty Opinions recommendation of Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725402243.793506131 ◽

2015 ◽

Author(s):

Jan Starý ◽

Michaela Kotrová

Keyword(s):

Prospective Study ◽

Lymphoblastic Leukaemia ◽

Clinical Utility ◽

Residual Disease ◽

A Prospective Study ◽

Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia

10.1111/j.1365-2141.2006.06056.x ◽

2006 ◽

Vol 133 (4) ◽

pp. 382-388 ◽

Cited By ~ 16

Author(s):

Vincent H. J. Velden ◽

Patricia G. Hoogeveen ◽

Rob Pieters ◽

Jacques J. M. Dongen

Keyword(s):

Bone Marrow ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Disease Monitoring ◽

Minimal Residual Disease Monitoring ◽

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

Leukemia ◽

10.1038/sj.leu.2400841 ◽

1997 ◽

Vol 11 (10) ◽

pp. 1732-1741 ◽

Cited By ~ 58

Author(s):

L Foroni ◽

LA Coyle ◽

M Papaioannou ◽

JC Yaxley ◽

MF Cole Sinclair ◽

...

Keyword(s):

Treatment Response ◽

Lymphoblastic Leukaemia ◽

Molecular Detection ◽

Residual Disease ◽

Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR

Molecular and Cellular Probes ◽

10.1006/mcpr.2001.0348 ◽

2001 ◽

Vol 15 (2) ◽

pp. 99-103 ◽

Cited By ~ 4

Author(s):

A. Lal ◽

E. Kwan ◽

M. Haber ◽

M.D. Norris ◽

G.M. Marshall

Keyword(s):

Lymphoblastic Leukaemia ◽

Peripheral Blood ◽

Residual Disease ◽

Clinical Relapse ◽

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

The Lancet ◽

10.1016/s0140-6736(01)06355-3 ◽

2001 ◽

Vol 358 (9289) ◽

pp. 1239-1241 ◽

Cited By ~ 157

Author(s):

Cornelia Eckert ◽

Andrea Biondi ◽

Karlheinz Seeger ◽

Giovanni Cazzaniga ◽

Reinhard Hartmann ◽

...

Keyword(s):

Lymphoblastic Leukaemia ◽

Prognostic Value ◽

Residual Disease ◽

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study

The Lancet Oncology ◽

10.1016/s1470-2045(15)70082-3 ◽

2015 ◽

Vol 16 (4) ◽

pp. 465-474 ◽

Cited By ~ 93

Author(s):

Ching-Hon Pui ◽

Deqing Pei ◽

Elaine Coustan-Smith ◽

Sima Jeha ◽

Cheng Cheng ◽

...

Keyword(s):

Prospective Study ◽

Lymphoblastic Leukaemia ◽

Clinical Utility ◽

Residual Disease ◽

A Prospective Study ◽

Faculty Opinions recommendation of Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718250462.793490105 ◽

2014 ◽

Author(s):

Jan Starý ◽

Michaela Kotrová

Keyword(s):

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Before And After ◽

Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real-time polymerase chain reaction

10.1046/j.1365-2141.2000.02029.x ◽

2000 ◽

Vol 109 (2) ◽

pp. 430-434 ◽

Cited By ~ 14

Author(s):

Edward Kwan ◽

Murray D. Norris ◽

Ling Zhu ◽

Daniella Ferrara ◽

Glenn M. Marshall ◽

...

Keyword(s):

Polymerase Chain Reaction ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Simultaneous Detection ◽

Chain Reaction ◽

Polymerase Chain ◽

Minimal Residual ◽

Detection And Quantification

Test trial of spike‐in immunoglobulin heavy‐chain ( IGH ) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia

10.1111/bjh.16571 ◽

2020 ◽

Vol 189 (4) ◽

Author(s):

Guilherme Navarro Nilo Giusti ◽

Patrícia Yoshioka Jotta ◽

Caroline de Oliveira Lopes ◽

Monica Aparecida Ganazza ◽

Amilcar Cardoso Azevedo ◽

...

Keyword(s):

Next Generation Sequencing ◽

Test Trial ◽

Heavy Chain ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia

10.1046/j.1365-2141.2001.02922.x ◽

2001 ◽

Vol 114 (2) ◽

pp. 281-289 ◽

Cited By ~ 16

Author(s):

Séverine Drunat ◽

Martine Olivi ◽

Ghislaine Brunie ◽

Bernard Grandchamp ◽

Etienne Vilmer ◽

...

Keyword(s):

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Disease Assessment ◽